- Home
- TC vs ALZN Comparison
TC vs ALZN Comparison
Compare TC & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- ALZN
- Stock Information
- Founded
- TC 2010
- ALZN 2016
- Country
- TC China
- ALZN United States
- Employees
- TC N/A
- ALZN N/A
- Industry
- TC Business Services
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- TC Consumer Discretionary
- ALZN Health Care
- Exchange
- TC Nasdaq
- ALZN Nasdaq
- Market Cap
- TC 2.4M
- ALZN 2.6M
- IPO Year
- TC 2018
- ALZN 2021
- Fundamental
- Price
- TC $0.85
- ALZN $3.03
- Analyst Decision
- TC
- ALZN Strong Buy
- Analyst Count
- TC 0
- ALZN 1
- Target Price
- TC N/A
- ALZN $180.00
- AVG Volume (30 Days)
- TC 231.9K
- ALZN 4.5M
- Earning Date
- TC 07-01-2025
- ALZN 07-29-2025
- Dividend Yield
- TC N/A
- ALZN N/A
- EPS Growth
- TC N/A
- ALZN N/A
- EPS
- TC N/A
- ALZN N/A
- Revenue
- TC $6,737,269.00
- ALZN N/A
- Revenue This Year
- TC N/A
- ALZN $322.64
- Revenue Next Year
- TC N/A
- ALZN N/A
- P/E Ratio
- TC N/A
- ALZN N/A
- Revenue Growth
- TC N/A
- ALZN N/A
- 52 Week Low
- TC $0.46
- ALZN $2.90
- 52 Week High
- TC $4.30
- ALZN $135.54
- Technical
- Relative Strength Index (RSI)
- TC 58.22
- ALZN 37.30
- Support Level
- TC $0.77
- ALZN $2.90
- Resistance Level
- TC $0.95
- ALZN $3.07
- Average True Range (ATR)
- TC 0.08
- ALZN 0.27
- MACD
- TC -0.01
- ALZN 0.03
- Stochastic Oscillator
- TC 50.00
- ALZN 6.16
About TC TuanChe Limited
Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.